PPA
RLAY icon

Parametric Portfolio Associates’s Relay Therapeutics RLAY Stock Holding History

Parametric Portfolio Associates’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.25M Buy
75,283
+35,040
+87% +$850K ﹤0.01% 2359
2021
Q4 		$1.24M Sell
40,243
-2,740
-6% -$86.6K ﹤0.01% 2695
2021
Q3 		$1.35M Buy
42,983
+4,241
+11% +$143K ﹤0.01% 2661
2021
Q2 		$1.42M Buy
38,742
+8,923
+30% +$294K ﹤0.01% 2615
2021
Q1 		$1.03M Buy
29,819
+8,272
+38% +$359K ﹤0.01% 3152
2020
Q4 		$895K Buy
21,547
+6,868
+47% +$310K ﹤0.01% 3102
2020
Q3 		$625K Buy
+14,679
New +$560K ﹤0.01% 3162

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parametric Portfolio Associates's RLAY Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Relay Therapeutics (RLAY) stake by 87% in Q1 2022, buying an estimated $850K and bringing the position to 75,283 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2359.

Parametric Portfolio Associates first reported a position in RLAY in Q3 2020 and has held it in 7 quarters since. 140 funds tracked by Wall St. Rank hold RLAY as of Q1 2022.

  • Parametric Portfolio Associates held 75,283 shares of Relay Therapeutics worth $2.25M as of Q1 2022.
  • Parametric Portfolio Associates bought 35,040 Relay Therapeutics shares in Q1 2022, an estimated $850K.
  • Relay Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2359 holding.
  • Parametric Portfolio Associates first reported a position in Relay Therapeutics in Q3 2020 and has held it in 7 quarters since.
  • 140 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.